# Ginseng Memory Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/ginseng-memory-randomized-trial-evidence-review
Category: evidence-review
Summary: Ginseng Memory Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomi
Last reviewed: 2026-06-03
Reviewed by: Migaku Evidence Review
# Ginseng Memory Randomized Trial: What the Evidence Says

## Quick Answer

Ginseng Memory Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and Safety of TESTOPEAK ™ in Improving Symptoms of Andropause in Korean Men: An 8-Week, Single-Center, Randomized, Parallel-Group, Placebo-Controlled Trial | randomized trial | 2 | 2026-04-01 | 10.1177/15579883261423878 |
| Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine | narrative review | 3 | 2026-02-03 | 10.1002/fsn3.71486 |

## What The Sources Report

- The effects of decreased male hormones include osteoporosis, loss of muscle mass and increased body fat, resulting in decreased physical function, facial flushing, erectile dysfunction, lipid metabolism-related cholesterol issues, decreased vitality, depression, sleep disorders, attention deficit and systemic fatigue (;;). [Kwon Han Ol (2026); evidence level 2]
- Matsumoto, 2002 Payne & Hales, 2004 Midzak et al., 2009 Symptoms of andropause occur as a result of decreased androgen levels; testosterone levels are annually decreased by 1% to 2%. [Kwon Han Ol (2026); evidence level 2]
- Ginsenosides are the prime pharmacologically active compounds responsible for the medicinal properties of ginseng, which are also found in many otherspecies, includingand. [Cortés Hernán (2026); evidence level 3]
- Some studies have reported reduced plasma concentrations of warfarin and enhanced aspirin bioavailability after ginseng intake, indicating possible pharmacokinetic and pharmacodynamic interactions. [Cortés Hernán (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For ginseng memory randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Kwon Han Ol (2026). Efficacy and Safety of TESTOPEAK ™ in Improving Symptoms of Andropause in Korean Men: An 8-Week, Single-Center, Randomized, Parallel-Group, Placebo-Controlled Trial. DOI: 10.1177/15579883261423878. PMCID: PMC13051131. PMID: 41923399. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ https://us.sagepub.co.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13051131/
- Cortés Hernán (2026). Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine. DOI: 10.1002/fsn3.71486. PMCID: PMC12868925. PMID: 41648642. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12868925/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.